Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma

Peripheral T cell lymphomas are an aggressive group of non-Hodgkin lymphomas with poor outcomes for most subtypes and no accepted standard of care for relapsed patients. This study evaluated the efficacy and safety of forodesine, a novel purine nucleoside phosphorylase inhibitor, in patients with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Dai, Tsukasaki, Kunihiro, Uchida, Toshiki, Maeda, Yoshinobu, Shibayama, Hirohiko, Nagai, Hirokazu, Kurosawa, Mitsutoshi, Suehiro, Yoko, Hatake, Kiyohiko, Ando, Kiyoshi, Yoshida, Isao, Hidaka, Michihiro, Murayama, Tohru, Okitsu, Yoko, Tsukamoto, Norifumi, Taniwaki, Masafumi, Suzumiya, Junji, Tamura, Kazuo, Yamauchi, Takahiro, Ueda, Ryuzo, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334730/
https://www.ncbi.nlm.nih.gov/pubmed/29974231
http://dx.doi.org/10.1007/s00277-018-3418-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334730/
https://www.ncbi.nlm.nih.gov/pubmed/29974231
http://dx.doi.org/10.1007/s00277-018-3418-2

Ejemplares similares